CHING-WEI DAVID TZENG to Double-Blind Method
This is a "connection" page, showing publications CHING-WEI DAVID TZENG has written about Double-Blind Method.
Connection Strength
0.038
-
Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial. Lancet Oncol. 2023 12; 24(12):1387-1398.
Score: 0.038